Role of SHIP-1 in the Adaptive Immune Responses to Aeroallergen in the Airway
Open Access
- 30 November 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (11), e14174
- https://doi.org/10.1371/journal.pone.0014174
Abstract
Th2-dominated inflammatory response in the airway is an integral component in the pathogenesis of allergic asthma. Accumulating evidence supports the notion that the phosphoinositide 3-kinase (PI3K) pathway is involved in the process. We previously reported that SHIP-1, a negative regulator of the PI3K pathway, is essential in maintaining lung immunohomeostasis, potentially through regulation of innate immune cells. However, the function of SHIP-1 in adaptive immune response in the lung has not been defined. We sought to determine the role of SHIP-1 in adaptive immunity in response to aeroallergen stimulation in the airway. SHIP-1 knockout (SHIP-1−/−) mice on BALB/c background were immunized with ovalbumin (OVA) plus aluminum hydroxide, a strong Th2-inducing immunization, and challenged with OVA. Airway and lung inflammation, immunoglobulin response, Th2 cytokine production and lymphocyte response were analyzed and compared with wild type mice. Even though there was mild spontaneous inflammation in the lung at baseline, SHIP-1−/− mice showed altered responses, including less cell infiltration around the airways but more in the parenchyma, less mucus production, decreased Th2 cytokine production, and diminished serum OVA-specific IgE, IgG1, but not IgG2a. Naïve and OVA sensitized SHIP-1−/− T cells produced a lower amount of IL-4. In vitro differentiated SHIP-1−/− Th2 cells produced less IL-4 compared to wild type Th2 cells upon T cell receptor stimulation. These findings indicate that, in contrast to its role as a negative regulator in the innate immune cells, SHIP-1 acts as a positive regulator in Th2 cells in the adaptive immune response to aeroallergen. Thus any potential manipulation of SHIP-1 activity should be adjusted according to the specific immune response.Keywords
This publication has 23 references indexed in Scilit:
- Inhibition of phosphoinositide 3‐kinase δ attenuates allergic airway inflammation and hyperresponsiveness in murine asthma modelThe FASEB Journal, 2006
- An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma modelInternational Immunopharmacology, 2005
- Phosphoinositide 3-kinase in T cell activation and survivalBiochemical Society Transactions, 2004
- Blockade of Inflammation and Airway Hyperresponsiveness in Immune-sensitized Mice by Dominant-Negative Phosphoinositide 3-Kinase–TATThe Journal of Experimental Medicine, 2003
- Evidence That SHIP-1 Contributes to Phosphatidylinositol 3,4,5-Trisphosphate Metabolism in T Lymphocytes and Can Regulate Novel Phosphoinositide 3-Kinase EffectorsThe Journal of Immunology, 2002
- Structure, function, and biology of SHIP proteinsGenes & Development, 2000
- The Inositol Polyphosphate 5-Phosphatase Ship Is a Crucial Negative Regulator of B Cell Antigen Receptor SignalingThe Journal of Experimental Medicine, 1998
- Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FeγRIIBNature, 1996
- Immunological Aspects of Allergic AsthmaAnnual Review of Immunology, 1994
- Ultrastructure of airways in children with asthmaHistopathology, 1978